Planning for potential disruption in 2023 will be crucial for pharmaceutical companies that wish to mitigate supply chain woes further down the line. The situation regarding COVID-19 in China is already being hailed as a potential source of supply chain disruption, with some organisations…
Source: www.pmlive.com – Read more
Stopping GLP-1 drugs often brings weight back. A small trial suggests ways to slow it
In a randomized pilot trial of 39 adults, researchers found that participants receiving medically tailored meals or Noom regained about 3.6% of their body weight
